Inventor · disambiguated record
Anirban Kundu
Also filed as: KUNDU ANIRBAN
27 granted patents·15 pending applications·1,456 citations·filing 2003–2025
98Inventor score
Top patents by PatentIndex Score
42 records- 0199US7871607B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2005·Granted Jan 18, 2011·128 cites·32 claims
- 0299US7846431B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Dec 7, 2010·89 cites·18 claims
- 0399US7829081B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2010·Granted Nov 9, 2010·92 cites·21 claims
- 0499US7767429B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2004·Granted Aug 3, 2010·250 cites·52 claims
- 0598US10016491B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2015·Granted Jul 10, 2018·28 cites·28 claims
- 0698US8772246B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2012·Granted Jul 8, 2014·81 cites·24 claims
- 0798US8580252B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2012·Granted Nov 12, 2013·91 cites·34 claims
- 0898US8431380B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS·Filed 2009·Granted Apr 30, 2013·88 cites·33 claims
- 0998US8431124B2Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)BOOKBINDER LOUIS H·Filed 2009·Granted Apr 30, 2013·71 cites·21 claims
- 1098US8257699B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2011·Granted Sep 4, 2012·80 cites·23 claims
- 1198US8202517B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2009·Granted Jun 19, 2012·91 cites·28 claims
- 1298US8105586B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2010·Granted Jan 31, 2012·90 cites·26 claims
- 1397US10588983B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2018·Granted Mar 17, 2020·27 cites·10 claims
- 1497US9677061B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofBOOKBINDER LOUIS H·Filed 2010·Granted Jun 13, 2017·32 cites·30 claims
- 1597US9211315B2Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2014·Granted Dec 15, 2015·36 cites·29 claims
- 1697US8765685B2Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)BOOKBINDER LOUIS·Filed 2012·Granted Jul 1, 2014·63 cites·23 claims
- 1796US10286044B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2017·Granted May 14, 2019·14 cites·22 claims
- 1896US9677062B2Hyaluronidase and factor VIII compositionsBOOKBINDER LOUIS H·Filed 2011·Granted Jun 13, 2017·22 cites·25 claims
- 1996US7544499B2Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2003·Granted Jun 9, 2009·49 cites·17 claims
- 2093US11325948B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPLEXUMA BIOTECH CORP·Filed 2020·Granted May 10, 2022·6 cites·27 claims
- 2193US9562223B2Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)HALOZYME INC·Filed 2014·Granted Feb 7, 2017·10 cites·24 claims
- 2292US12258574B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Granted Mar 25, 2025·1 cites·26 claims
- 2392US11723959B2Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptideHALOZYME INC·Filed 2020·Granted Aug 15, 2023·2 cites·13 claims
- 2491US10898551B2Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2019·Granted Jan 26, 2021·2 cites·41 claims
- 2590US8815558B2Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofFROST GREGORY I·Filed 2009·Granted Aug 26, 2014·9 cites·14 claims
- 2689US2023321203A1SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOFHALOZYME INC·Filed 2023·Application pending·0 cites
- 2788US11111505B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2017·Granted Sep 7, 2021·3 cites·21 claims
- 2887US12325728B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79BEXUMA BIOTECH CORP·Filed 2022·Granted Jun 10, 2025·1 cites·26 claims
- 2980US2023257776A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Application pending·0 cites
- 3077US2025236889A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2025·Application pending·0 cites
- 3173US2021403952A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 3265US2014037613A1Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesBOOKBINDER LOUIS H·Filed 2013·Application pending·0 cites
- 3364US2014341875A1Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereofHALOZYME INC·Filed 2014·Application pending·0 cites
- 3457US2023357436A1Anti-idiotype compositions and methods of use thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 3556US2023044451A1Methods and compositions for the delivery of modified lymphocytes and/or retroviral particlesEXUMA BIOTECH CORP·Filed 2022·Application pending·0 cites
- 3654US2006104968A1Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanasesHALOZYME INC·Filed 2005·Application pending·0 cites
- 3754US2023072955A1Chimeric antigen receptors to her2 and methods of use thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 3851US2023111159A1Methods and compositions for the delivery of modified lymphocyte aggregatesEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 3950US2022340927A1Methods and compositions for the modification and delivery of lymphocytesEXUMA BIOTECH CORP·Filed 2020·Application pending·0 cites
- 4050US2021317408A1Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcsEXUMA BIOTECH CORP·Filed 2019·Application pending·0 cites
- 4147US2015165059A1Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanasesHALOZYME INC·Filed 2015·Application pending·0 cites
- 4239US2009123367A1Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble GlycosaminoglycanasesDELFMEMS·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anirban Kundu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →